Archives
- 2008.12.04: I'm Back - Is Biotech?
- 2008.09.08: Medivation -- Does the Tsar Have New Clothes?
- 2008.07.07: The Bipolar Biotech Market
- 2008.05.28: No Barriers for Barrier (BTRX)
- 2008.05.22: CitiGroup Conference -- Healthcare Losers
- 2008.04.22: Avant Immunotherapeutics (AVAN) -- What Gives?
- 2008.04.10: To Antigenics or Not to Antigenics?
- 2008.04.03: A Biotech Turnaround?
- 2008.03.25: Drugs: Penny Wise, But a Pound Foolish
- 2008.03.19: Amgen (AMGN) -- Whither Thou Goest?
- 2008.03.11: Cepheid (CPHD): A False Hit Based on a False Claim
- 2008.02.27: Phase III Trials for PRAN
- 2008.02.26: Prana Biotechnology (PRAN): A Challenge for the FDA
- 2008.02.21: YM BioSciences (YMI)
- 2008.02.20: BioMS Medical (MS.TO)
- 2008.02.10: Accuray (ARAY)
- 2008.02.04: BioCryst (BCRX): Fugheddaboudit!
- 2008.01.28: The Tragedy of NitroMed (NTMD)
- 2008.01.21: Inhaled Insulin - Alkermes/Lilly, Mannkind (MNKD)
- 2008.01.12: Response to Jimmy T. about Xoma (XOMA)
- 2008.01.12: Response to Denny About Dendreon (DNDN)
- 2008.01.11: Curis (CRIS): Has This Old Dog Learned New Tricks?
- 2008.01.07: Amgen (AMGN) Redux
- 2008.01.02: MRSA -- Is it an Investment Opportunity? CPHD, BSLN
- 2007.12.24: Happy New Year
- 2007.12.24: Merck (MRK) - Time (For You) to Run?
- 2007.12.18: Response About Amgen's Bone Density Drugs
- 2007.12.14: Correction: VaxGen (VXGN.PK)
- 2007.12.12: Vaxgen Redux -- VXGN.PK
- 2007.12.10: The Non Orphan, Orphan Drug Company: Questcor (QSC)
- 2007.12.03: Amgen (AMGN) Fails, Yet Again
- 2007.11.30: Elan (ELAN) -- Not Yet
- 2007.11.29: Biogen-Idec: Time To Buy?
- 2007.11.07: Day Two at Rodman and Renshaw
- 2007.11.06: Enough Already! I Can Read!
- 2007.10.30: Oct. 30 - MRSA Update: Cepheid (CPHD), Basilea (SWX:BSLN) and Nektar (NKTR)
- 2007.10.29: Anecdotes -- JNJ, CPHD, AMLN
- 2007.10.23: Pfizer (PFE) Follies Part One
- 2007.10.18: Investing in MRSA
- 2007.10.08: Generic Biologics? Fugheddaboudit!
- 2007.10.08: Alzheimer's Disease -- Fighting The Biggest Public Health Threat Ever
- 2007.10.08: The Ultimate in Personalized Medicine and (For Now) Hype
- 2007.10.05: Amgen (AMGN): The Anemic Biotech
- 2007.10.04: In Memoriam -- James Michaels
- 2007.10.02: A Hidden Company Pursuing RNA Interference - Cepheid (CPHD)
- 2007.09.30: Shame on the Congressional Black Caucus - Yes, This is About Biotech
- 2007.09.24: UBS Global Life Sciences Conference
- 2007.09.20: Morons and Other Biotech Management Types
- 2007.09.18: Cancer Immunotherapy: Is the Hype Over and the Hope Beginning?
- 2007.09.18: Hillary Care - A Must Say Opinion
- 2007.09.17: RNA Interference: NOT Better Late Than Never
- 2007.09.11: More, Actually Less, in Genomics
- 2007.08.28: Biotech at the Beach -- Genomics, Part I
- 2007.08.23: Biotech at the Beach -- Hot Technology, Part I
- 2007.08.16: Restless Toe Syndrome
- 2007.08.16: Biotech: Is It Time to Buy?
- 2007.08.13: The Poverty of Drug Development and the FDA
- 2007.08.10: The FDA and Life Saving Drugs - Redux
- 2007.08.10: Markets Swoon - and Biotech Moves Up?
- 2007.08.08: Biotech Stocks: Something for Everyone
- 2007.08.06: Investing in Women's Health
- 2007.08.04: Biotechs Getting Blitzed
- 2007.08.02: Biotech and Barry Bonds
- 2007.07.31: Pfizer (PFE) and GlaxoSmithKline (GSK): Value or Value Trap?
- 2007.07.30: Cal Ripken: A Biotech Role Model
- 2007.07.22: Spectrum Pharmaceuticals and Satraplatin
- 2007.07.18: Harry Potter and Medicine of the Future
- 2007.07.17: Why Biotech and Not Big Pharma
- 2007.07.16: Healthcare Spending May be Good For You
- 2007.07.12: Byetta + Oral Meds Versus Insulin
- 2007.07.12: RNAi - Next Phase or Next Fad?
- 2007.07.11: China Loses It's Head Over Drug Regulation
- 2007.07.09: A Look at Three Busted Biotech IPOs
- 2007.07.06: MERCK, VIOXX AND THE FDA
- 2007.07.02: Acomplia Goes Away -- It's a Good Thing
- 2007.06.30: Do You Believe in Miracles?
- 2007.06.27: Genomics: Are There Winners Yet?
- 2007.06.26: Move Over Insulin, Here Comes Byetta
- 2007.06.26: Biogenerics: What, Where, When, Why, Who
- 2007.06.22: The Future of Diabetes: Part I
- 2007.06.21: The Future of Inhalable Insulin
- 2007.06.14: Acomplia -- Score One for the FDA
- 2007.06.11: Dendreon Redux (DNDN)
- 2007.05.24: Response to Spectrum (SPPI) Question
- 2007.05.21: Biotech Catalysts
- 2007.05.14: Investing In a Disease
- 2007.05.10: Dendreon (DNDN), Provenge and the FDA
- 2007.05.02: MedImmune -- What Was AstraZeneca Thinking?
- 2007.04.30: Response to Neurochem (NRMX) Inquiry
- 2007.04.30: Response About IMPACT Trial
- 2007.04.25: Comment on Dor
- 2007.04.23: Response to Accusation about DNDN
- 2007.04.23: Response to DNDN
- 2007.04.17: Vertex (VRTX) -- Is it Worth The Price?
- 2007.04.09: Cell Genesys (CEGE) and Dendreon (DNDN)
- 2007.04.09: Repsonse About Neurochem (NRMX)
- 2007.04.01: Dendreon and Provenge - The FDA Advisory Panel Meeting
- 2007.03.26: An Important Week in the Fight Against Cancer
- 2007.03.26: AMGEN
- 2007.03.19: Nitromed (NTMD) Question
- 2007.03.19: Disease Overview: Diabetes and Patient Convenience
- 2007.03.12: Government Contracts: No Garden of (Hollis) Eden
- 2007.03.05: Vaccines - Boring, Profitable, Evergreen
- 2007.03.02: Market Irrationality, is CEGE an Opportunity?
- 2007.02.26: Alzheimer's Disease and Neurochem
- 2007.02.20: GENVEC
- 2007.02.20: Response: PMTI, Exubera, CEGE
- 2007.02.12: Question about Celgene
- 2007.02.12: BioInvestor Conference
- 2007.02.07: Reponse to ALKS/NKTR
